📊 DBVTF Key Takeaways
Is DBV Technologies S.A. (DBVTF) a Good Investment?
DBV Technologies is experiencing severe financial distress with collapsing revenue (-73.6% YoY), massive operating losses (-$102M), and negative free cash flow (-$86.2M), indicating the company is burning through its cash reserves at an unsustainable rate. Despite maintaining adequate liquidity currently, the company's fundamental business model is broken with a -2046% net margin, and at current burn rates, cash runway appears critically limited.
DBV Technologies' fundamentals are very weak: revenue fell 73.6% year over year while operating and net losses exceeded $102M, producing deeply negative margins and returns on capital. The balance sheet is not heavily levered and cash of $69.84M provides some support, but the current cash burn rate and lack of profitable growth make the financial profile highly fragile.
Why Buy DBV Technologies S.A. Stock? DBVTF Key Strengths
- Strong current liquidity position with $69.8M cash and 1.80x current ratio
- Minimal debt burden with only $510K long-term debt and 0.01x debt/equity ratio
- Modest insider activity suggests some management engagement despite challenges
- Low financial leverage with debt/equity of 0.01x and only $0.51M of long-term debt
- Cash and equivalents of $69.84M still provide near-term funding flexibility
- Current and quick ratios of 1.80x indicate acceptable short-term liquidity
DBVTF Stock Risks: DBV Technologies S.A. Investment Risks
- Revenue collapse of 73.6% YoY indicates failed commercialization or market rejection of core products
- Operating cash burn of $86.2M annually unsustainable given current cash reserves of $69.8M
- Massive operating losses with -2043.8% operating margin suggest fundamental business model failure
- Negative ROE of -193.2% and ROA of -92.4% indicate severe capital inefficiency
- Complete dependence on cash reserves for survival with no path to profitability visible
- Revenue contraction of 73.6% YoY suggests weak growth quality and limited commercial traction
- Operating cash flow of -$86.01M and free cash flow of -$86.17M imply heavy cash burn relative to available cash
- Net margin of -2046.0% and ROE of -193.2% indicate an unsustainable profitability profile
Key Metrics to Watch
- Quarterly revenue trend - watch for stabilization or further deterioration
- Operating cash flow and monthly burn rate - critical for estimating runway
- Cash and equivalents balance - monitor depletion timeline
- Operating expenses and headcount reduction initiatives - necessary for survival
- Product pipeline and regulatory milestone achievements - assess future revenue potential
- Quarterly operating cash burn versus cash balance
- Revenue trend and any improvement in operating loss margin
DBV Technologies S.A. (DBVTF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
DBV Technologies S.A. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
DBVTF Profit Margin, ROE & Profitability Analysis
DBVTF vs Healthcare Sector: How DBV Technologies S.A. Compares
How DBV Technologies S.A. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is DBV Technologies S.A. Stock Overvalued? DBVTF Valuation Analysis 2026
Based on fundamental analysis, DBV Technologies S.A. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
DBV Technologies S.A. Balance Sheet: DBVTF Debt, Cash & Liquidity
DBVTF Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: DBV Technologies S.A.'s revenue has declined by 50% over the 5-year period, indicating business contraction. The most recent EPS of $-1.17 indicates the company is currently unprofitable.
DBVTF Revenue Growth, EPS Growth & YoY Performance
DBVTF Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.1M | -$27.1M | $-0.24 |
| Q2 2025 | $1.2M | -$27.1M | $-0.31 |
| Q1 2025 | $753.0K | -$27.1M | $-0.26 |
| Q3 2024 | $1.1M | -$16.7M | $-0.17 |
| Q2 2024 | $1.2M | -$20.6M | $-0.26 |
| Q1 2024 | $1.4M | -$20.6M | $-0.22 |
| Q3 2023 | $2.1M | -$16.7M | $-0.17 |
| Q2 2023 | $1.5M | -$16.7M | $-0.26 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
DBV Technologies S.A. Dividends, Buybacks & Capital Allocation
DBVTF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for DBV Technologies S.A. (CIK: 0001613780)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DBVTF
What is the AI rating for DBVTF?
DBV Technologies S.A. (DBVTF) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 92% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are DBVTF's key strengths?
Claude: Strong current liquidity position with $69.8M cash and 1.80x current ratio. Minimal debt burden with only $510K long-term debt and 0.01x debt/equity ratio. ChatGPT: Low financial leverage with debt/equity of 0.01x and only $0.51M of long-term debt. Cash and equivalents of $69.84M still provide near-term funding flexibility.
What are the risks of investing in DBVTF?
Claude: Revenue collapse of 73.6% YoY indicates failed commercialization or market rejection of core products. Operating cash burn of $86.2M annually unsustainable given current cash reserves of $69.8M. ChatGPT: Revenue contraction of 73.6% YoY suggests weak growth quality and limited commercial traction. Operating cash flow of -$86.01M and free cash flow of -$86.17M imply heavy cash burn relative to available cash.
What is DBVTF's revenue and growth?
DBV Technologies S.A. reported revenue of $5.0M.
Does DBVTF pay dividends?
DBV Technologies S.A. does not currently pay dividends.
Where can I find DBVTF SEC filings?
Official SEC filings for DBV Technologies S.A. (CIK: 0001613780) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DBVTF's EPS?
DBV Technologies S.A. has a diluted EPS of $-0.82.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is DBVTF a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, DBV Technologies S.A. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is DBVTF stock overvalued or undervalued?
Valuation metrics for DBVTF: ROE of -193.2% (sector avg: 15%), net margin of -2,046.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy DBVTF stock in 2026?
Our dual AI analysis gives DBV Technologies S.A. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is DBVTF's free cash flow?
DBV Technologies S.A.'s operating cash flow is $-86.0M, with capital expenditures of $159.0K. FCF margin is -1,726.4%.
How does DBVTF compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -2,046.0% (avg: 12%), ROE -193.2% (avg: 15%), current ratio 1.80 (avg: 2).